Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis

Article Abstract:

Fulminant myocarditis appears to have an excellent prognosis if properly treated. Myocarditis is an inflammation of the heart that can cause heart failure. When it occurs rapidly over a brief period of time, it is called fulminant myocarditis. In a study of 147 patients with myocarditis, 93% of those with the fulminant type were alive 10 years later compared to 45% of those with the non-fulminant type. None of the patients with fulminant myocarditis had received a heart transplant.

Author: McCarthy, Robert E, III, Boehmer, John P., Hruban, Ralph H., Hutchins, Grover M., Kasper, Edward K., Hare, Joshua M., Baughman, Kenneth L.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2000

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Fulminant myocarditis

Article Abstract:

Patients with fulminant myocarditis apparently have an excellent prognosis and should receive aggressive treatment. Fulminant myocarditis is an inflammation of the heart that occurs rapidly and can lead to heart failure. However, many patients recover completely and a heart biopsy shows that their heart also recovers. Many will not even need a heart transplant. On the other hand, patients with non-fulminant myocarditis, although less sick, have a worse prognosis.

Author: Karliner, Joel S.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2000
Editorial

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy

Article Abstract:

The prognosis of patients with cardiomyopathy depends on the underlying condition that is causing the disease. Cardiomyopathy is the medical term for disease of the heart muscle. It can be caused by coronary artery disease and by many other conditions, including HIV infection, pregnancy, hypertension, substance abuse, connective tissue disease, and treatment with doxorubicin. In a study of 1,230 people with cardiomyopathy from various causes, women with pregnancy-related cardiomyopathy had the best prognosis and those with HIV infection, doxorubicin treatment, or infiltrative heart muscle diseases had the worst prognosis.

Author: Hruban, Ralph H., Kasper, Edward K., Hare, Joshua M., Baughman, Kenneth L., Felker, G. Michael, Thompson, Richard E., Clemetson, Diedre E., Howard, David L.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2000
Cardiomyopathy, Myocardial diseases

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Prognosis, Myocarditis
Similar abstracts:
  • Abstracts: Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy
  • Abstracts: Usefulness of posture training for patients with temporomandibular disorders. Identifying underdiagnosed rheumatic disorders among patients with TMD
  • Abstracts: Malabsorption due to cholecystokinin deficiency in a patient with autoimmune polyglandular syndrome type I. Positive Results on Tests for Steatorrhea in Persons Consuming Olestra Potato Chips
  • Abstracts: Associations of serum lipids with metabolic control and diet in young subjects with insulin-dependent diabetes mellitus in Finland
  • Abstracts: Effect of oral iodized oil on thyroid size and thyroid hormone metabolism in children with concurrent selenium and iodine deficiency
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2023 Advameg, Inc.